Proteus Digital Health Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Proteus Digital Health Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7433
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Proteus Digital Health Inc (Proteus) is a digital medicine company that develops and sells medicines for chronic diseases through in-house research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digital medicine, automatically gathers and communicates information about medication taking, activity and rest patterns. It consists of wearable and ingestible sensors, an application on a mobile device and a provider portal, which detects ingestions and physiological data. The company’s products are designed for family caregivers, clinicians, case workers, drug and device markets, and health systems. The company is funded by Carlyle, Essex Woodlands, Kaiser Permanente, Medtronic, Novartis, Otsuka, Oracle and ON Semiconductor, among others. Proteus is headquartered in Redwood City, California, the US.

Proteus Digital Health Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteus Digital Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteus Digital Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteus Digital Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteus Digital Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Proteus Digital Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Proteus Digital Health Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Proteus Digital Health Raises USD50 Million in Series H Financing Round 10
Vium Secures USD8.8 Million in Venture Funding 11
Proteus Digital Health Raises Additional USD52 Million in Series G Financing 12
Proteus Digital Health Raises US$63 Million In Series F Financing Round 13
Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 14
Proteus Digital Health Inc – Key Competitors 15
Proteus Digital Health Inc – Key Employees 16
Proteus Digital Health Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Feb 13, 2018: Proteus Digital Health Appoints Joseph Swedish As Board Director 18
Sep 05, 2017: Former U. S. Surgeon General Dr. Regina Benjamin Joins the Board of Proteus Digital Health 19
Aug 23, 2017: Senior Novartis Executive Joins Proteus Digital Health as Chief Financial Officer 20
Product News 21
Aug 24, 2018: Adherence to PrEP the HIV prevention drug is low. A new study suggests a pill with a tiny sensor might help 21
Other Significant Developments 23
Aug 14, 2018: Digital medicines value-based contract focused on improving patient outcomes established between Desert Oasis Healthcare and Proteus Digital Health 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Proteus Digital Health Inc, Medical Equipment, Key Facts 2
Proteus Digital Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Proteus Digital Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteus Digital Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteus Digital Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteus Digital Health Inc, Deals By Market, 2012 to YTD 2018 8
Proteus Digital Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Proteus Digital Health Raises USD50 Million in Series H Financing Round 10
Vium Secures USD8.8 Million in Venture Funding 11
Proteus Digital Health Raises Additional USD52 Million in Series G Financing 12
Proteus Digital Health Raises US$63 Million In Series F Financing Round 13
Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 14
Proteus Digital Health Inc, Key Competitors 15
Proteus Digital Health Inc, Key Employees 16
Proteus Digital Health Inc, Other Locations 17
Proteus Digital Health Inc, Subsidiaries 17

List of Figures
Proteus Digital Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Proteus Digital Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Proteus Digital Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Proteus Digital Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Proteus Digital Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteus Digital Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Proteus Digital Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteus Digital Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Proteus Digital Health Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Natera Inc (NTRA):企業の製品パイプライン分析2018
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • American Bridge Company:企業の戦略・SWOT・財務分析
    American Bridge Company - Strategy, SWOT and Corporate Finance Report Summary American Bridge Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Waste Management Inc (WM):企業の財務・戦略的SWOT分析
    Waste Management Inc (WM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • STRATEC Biomedical AG (SBS):企業の財務・戦略的SWOT分析
    Summary STRATEC Biomedical AG (STRATEC), formerly Stratec Biomedical Systems AG is a medical equipment provider that develops and manufactures automated systems for clinical diagnostics. The company provides instrumentation, data management, molecular solutions, and others. It offers data management …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MS Amlin plc:企業の戦略的SWOT分析
    MS Amlin plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Johnson Service Group plc (JSG):企業の財務・戦略的SWOT分析
    Summary Johnson Service Group plc (JSG) is a business and consumer service provider that provides textile services. The company provides dry cleaning and textile rental services. It offers dry cleaning services such as commercial dry cleaning, specialist textile consulting, garment aftercare service …
  • A. Menarini Asia-Pacific Holdings Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • Pharmaxis Ltd (PXS)-医療機器分野:企業M&A・提携分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lu …
  • Rashtriya Chemicals and Fertilizers Ltd (RCF):企業の財務・戦略的SWOT分析
    Summary Rashtriya Chemicals and Fertilizers Ltd (RCFL) is a chemical company that manufactures and markets fertilizers and industrial chemicals. The company offers industrial chemicals include methanol, mono methylamine, strong nitric acid, dilute nitric acid, sulphuric acid, sodium nitrite, anhydro …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Transfield Holdings Pty Ltd:企業の戦略的SWOT分析
    Transfield Holdings Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • ARCA biopharma Inc (ABIO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • OncoStem Diagnostics Pvt. Ltd:企業の製品パイプライン分析2018
    Summary OncoStem Diagnostics Pvt Ltd (OncoStem) is a provider of clinical trial solutions. The company develops multimaker prognostic and predictive testing enabling detecting and treating patients affected with cancer. It develops various tests in identifying patterns of repetition in cancer. OncoS …
  • Vallourec SA:企業の戦略・SWOT・財務情報
    Vallourec SA - Strategy, SWOT and Corporate Finance Report Summary Vallourec SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • University of Pittsburgh-製薬・医療分野:企業M&A・提携分析
    Summary University of Pittsburgh (Pitt) is an educational research institute that offers undergraduate, graduate and professional programs. The institute provides academic courses in different fields such as business, information sciences, health and rehabilitation, information sciences, engineering …
  • Goldcorp Inc:企業の戦略・SWOT・財務情報
    Goldcorp Inc - Strategy, SWOT and Corporate Finance Report Summary Goldcorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • CD Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CD Diagnostics Inc (CD Diagnostics), a subsidiary of Zimmer Biomet Holdings Inc, is a diagnostics company that develops immunoassays to improve patient outcomes. The company provides synovascure analytical tools. Its products are used in alpha defenses, CRP, hemoglobin tests, incubation of a …
  • Dover Corp (DOV):企業の財務・戦略的SWOT分析
    Dover Corp (DOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Saskatchewan Power Corporation:企業の発電所・SWOT分析2018
    Saskatchewan Power Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆